Literature DB >> 10683537

Hepatitis B epidemiology in Latin America.

J Tanaka1.   

Abstract

The available data on prevalence of hepatitis B virus (HBV) infection in Latin America are incomplete and largely based on analysis of blood banks, which are not stratified by age or social class. An epidemiological study was recently undertaken in six countries in Latin America to update the data. The highest seroprevalence of antibody to the HBV core antigen (anti-HBc) was found in the Dominican Republic (21.4%), followed by Brazil (7.9%), Venezuela (3.2%) and Argentina (2.1%). The lowest seroprevalence was found in Mexico (1.4%) and Chile (0.6%). The seroprevalence in different regions of Brazil varied from 21% in Manaus to 1.2% in Fortaleza. There were no differences in seroprevalence of anti-HBc between females and males except in Brazil (significantly higher in males) and in the Dominican Republic (significantly higher in females). In Brazil alone, higher seroprevalence was associated with lower socioeconomic class. In both the Dominican Republic and Brazil, seroprevalence was high in childhood, and in Brazil and Argentina, anti-HBc was detected in 3.0-6.6% of children up to 1 year old, suggesting vertical transmission. Other risk factors included dental and surgical procedures, sexual activity and tattooing. There was an increase in seroprevalence in all countries at or after adolescence, suggesting that sexual activity is a major route of transmission.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683537     DOI: 10.1016/s0264-410x(99)00455-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Tattoos: a photo essay.

Authors:  M H Christensen
Journal:  Public Health Rep       Date:  2000 Sep-Oct       Impact factor: 2.792

2.  High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil.

Authors:  C A Blal; S R L Passos; C Horn; I Georg; M G Bonecini-Almeida; V C Rolla; L De Castro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

3.  Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?

Authors:  Mónica Viviana Alvarado-Mora; María Fernanda Gutierrez Fernandez; Michele Soares Gomes-Gouvêa; Raymundo Soares de Azevedo Neto; Flair José Carrilho; João Renato Rebello Pinho
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

4.  Hepatitis B: Epidemiology and prevention in developing countries.

Authors:  Elisabetta Franco; Barbara Bagnato; Maria Giulia Marino; Cristina Meleleo; Laura Serino; Laura Zaratti
Journal:  World J Hepatol       Date:  2012-03-27

5.  Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.

Authors:  Márcia da Costa Castilho; Cintia Mara Costa de Oliveira; João Bosco de Lima Gimaque; Jorge Di Tommaso Leão; Wornei Silva Miranda Braga
Journal:  Am J Trop Med Hyg       Date:  2012-08-20       Impact factor: 2.345

Review 6.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  Incidence and mortality rates of selected infection-related cancers in Puerto Rico and in the United States.

Authors:  Ana P Ortiz; Marievelisse Soto-Salgado; William A Calo; Guillermo Tortolero-Luna; Cynthia M Pérez; Carlos J Romero; Javier Pérez; Nayda Figueroa-Vallés; Erick Suárez
Journal:  Infect Agent Cancer       Date:  2010-05-14       Impact factor: 2.965

Review 8.  Hepatitis B virus infection in Latin America: a genomic medicine approach.

Authors:  Sonia Roman; Alexis Jose-Abrego; Nora Alma Fierro; Griselda Escobedo-Melendez; Claudia Ojeda-Granados; Erika Martinez-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Global risk assessment of aflatoxins in maize and peanuts: are regulatory standards adequately protective?

Authors:  Felicia Wu; Shaina L Stacy; Thomas W Kensler
Journal:  Toxicol Sci       Date:  2013-06-12       Impact factor: 4.849

10.  Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients.

Authors:  Doaa M Elghannam; Rabab M Aly; Enas F Goda; Ehab E Eltoraby; Raghda E Farag
Journal:  Asian J Transfus Sci       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.